Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 1:32 AM
Ignite Modification Date:
2025-12-25 @ 1:32 AM
NCT ID:
NCT03654794
Eligibility Criteria:
Inclusion Criteria:
* adult (age \> 18 years old);
* phlebotomy as part of the maintenance treatment of hemochromatosis;
* having received the information on the protocol and not having indicated his opposition to participate;
* not receiving immunosuppressive therapy;
* not receiving drug treatment that can induce or inhibit the protein ABCB1 (Rifampicin, Carbamazepine, Phenobarbital, Phenytoin, Efavirenz, Amiodarone, azole antifungals, calcium channel blockers).
Exclusion Criteria:
* participation in another protocol whose procedures are incompatible with the realization of the study;
* adults who are subject to legal protection (protection of justice, guardianship) and persons deprived of their liberty;
* pregnant women.
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT03654794
Study Brief:
Protocol Section:
NCT03654794